Congratulations to IBD (Italian Biomedical Device), which has successfully passed Stage 2 of the EIC Accelerator—the most selective SME funding program at the European level—with its dialysis device, MyDial!
IBD is an innovative SME and biomedical device manufacturer, conceived in London and founded in Italy in 2014. Led by a team with over 10 years of experience in medical device design, IBD has raised over €1 million to date through business angel investments and grants.
About the project
MyDial is a new portable hemodialysis system designed to be used with customized, cost-effective disposable accessories. It is engineered to significantly reduce the economic impact of chronic dialysis treatment and to enable the transition to out-of-hospital care.